Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection. uri icon

authors

  • Ryan Carnahan, PharmD, MS, BCPP
  • Chen, Chih-Ying
  • Panozzo, Catherine A
  • Toh, Sengwee
  • Katcoff, Hannah
  • Woodworth, Tiffany
  • Iyer, Aarthi
  • Axtman, Sophia
  • Chrischilles, Elizabeth A
  • Kuntz, Jennifer L
  • Wang, Shirley V
  • Fuller, Candace
  • Gagne, Joshua J
  • Leonard, Charles E
  • Hennessy, Sean
  • Meyer, Tamra
  • Archdeacon, Patrick

publication date

  • January 1, 2018